APPENDICES - NIHR Health Technology Assessment Programme
APPENDICES - NIHR Health Technology Assessment Programme
APPENDICES - NIHR Health Technology Assessment Programme
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
DOI: 10.3310/hta14370 <strong>Health</strong> <strong>Technology</strong> <strong>Assessment</strong> 2010; Vol. 14: No. 37<br />
80. Pech O, Gossner L, May A, Rabenstein T, Vieth M,<br />
Stolte M, et al. Long-term results of photodynamic<br />
therapy with 5-aminolevulinic acid for superficial<br />
Barrett’s cancer and high-grade intraepithelial<br />
neoplasia. Gastrointest Endosc 2005;62:24–30.<br />
81. Pech O, Gossner L, May AD, Stolte M, Ell C. Long<br />
term results of PDT for early neoplasia in Barrett’s<br />
esophagus. Gastrointest Endosc 2004;59:A257.<br />
82. Peters F, Kara M, Rosmolen W, Aalders M, Ten<br />
Kate F, Krishnadath K, et al. Poor results of<br />
5-aminolevulinic acid-photodynamic therapy for<br />
residual high-grade dysplasia and early cancer<br />
in barrett esophagus after endoscopic resection.<br />
Endoscopy 2005;37:418–24.<br />
83. Peters F, Kara M, Rosmolen W, ten Kate F, Bultje B,<br />
Krishnadath S, et al. Endoscopic resection combined<br />
with photodynamic therapy for high grade dysplasia<br />
and early cancer in Barrett’s esophagus. Gastrointest<br />
Endosc 2004;59:A251.<br />
84. Peters FP, Kara MA, Rosmolen WD, Aalders<br />
MCG, Ten Kate FJW, Bultje BC, et al. Endoscopic<br />
treatment of high-grade dysplasia and early stage<br />
cancer in Barrett’s esophagus. Gastrointest Endosc<br />
2005;61:506–14.<br />
85. Prasad GA, Wang KK, Buttar NS, Wongkeesong<br />
L-M, Krishnadath KK, Nichols FC, III, et al. Longterm<br />
survival following endoscopic and surgical<br />
treatment of high-grade dysplasia in Barrett’s<br />
esophagus. Gastroenterology 2007;132:1226–33.<br />
86. Prasad GA, Wang KK, Buttar NS, Wongkeesong<br />
L-M, Lutzke LS, Borkenhagen LS. Predictors of<br />
stricture formation after photodynamic therapy<br />
for high-grade dysplasia in Barrett’s esophagus.<br />
Gastrointest Endosc 2007;65:60–6.<br />
87. Rahmani EY, Rex DK, Ciaccia D, Turpin CS.<br />
Photodynamic therapy for ablation of esophageal<br />
high grade dysplasia and superficial cancer.<br />
Gastrointest Endosc 2000;51:3539.<br />
88. Rahmani EY, Turpin C, Arney K. Photodynamic<br />
therapy for dysplastic Barrett’s esophagus and early<br />
esophageal adenocarcinoma should be first line<br />
therapy! Gastrointest Endosc 2004;59:A250.<br />
89. Schembre DB, Huang JL, Lin OS, Cantone N, Low<br />
DE. Treatment of Barrett’s esophagus with early<br />
neoplasia: a comparison of endoscopic therapy and<br />
esophagectomy. Gastrointest Endosc 2008;67:595–<br />
601.<br />
90. Schweitzer VG. Photodynamic therapy: 1994<br />
treatment of benign and malignant upper<br />
aerodigestive tract disease. SPIE Proceedings Series<br />
1995;2371:403–17.<br />
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.<br />
91. Shah AK, Wolfsen HC, Hemminger LL, Shah<br />
AA, DeVault KR. Changes in esophageal motility<br />
after porfimer sodium photodynamic therapy for<br />
Barrett’s dysplasia and mucosal carcinoma. Dis<br />
Esophagus 2006;19:335–9.<br />
92. Sylantiev C, Schoenfeld N, Mamet R, Groozman<br />
GB, Drory VE. Acute neuropathy mimicking<br />
porphyria induced by aminolevulinic acid during<br />
photodynamic therapy. Muscle Nerve 2005;31:390–3.<br />
93. Triadafilopoulos G. Photodynamic therapy for the<br />
treatment of patients with Barrett’s high-grade<br />
dysplasia and mucosal adenocarcinoma. Nat Clin<br />
Pract Gastroenterol Hepatol 2005;2:136–7.<br />
94. van Hillegersberg R, Haringsma J, ten Kate FJW,<br />
Tytgat GNJ, van Lanschot JJB. Invasive carcinoma<br />
after endoscopic ablative therapy for high-grade<br />
dysplasia in Barrett’s oesophagus. Dig Surg<br />
2003;20:440–4.<br />
95. Wang KK, Buttar NS, Lutzke LS, Anderson MA,<br />
Krisnadath K. Long-term results of photodynamic<br />
therapy for Barrett’s esophagus. Gastrointest Endosc<br />
2000;51:4915.<br />
96. Wang KK, Gutta K, Laukka MA. Phototherapy<br />
of Barrett’s esophagus. SPIE Proceedings Series<br />
1994;2133:33–8.<br />
97. Wang KK, Song L, Buttar N, Papenfuss S, Lutzke<br />
L. Barretts esophagus after photodynamic therapy:<br />
Risk of cancer development during long term<br />
follow-up. Gastroenterology 2004;126:A50.<br />
98. Weiss A, Wiesinger H, Owen D. Photodynamic<br />
therapy of high grade dysplasia in Barrett’s<br />
esophagus: results from treatment of 17 patients.<br />
Gastrointest Endosc 2005;61:A145.<br />
99. Weiss AA, Wiesinger HAR, Owen D. Photodynamic<br />
therapy in Barrett’s esophagus: results of treatment<br />
of 17 patients. Can J Gastroenterol 2006;20:261–4.<br />
100. Wolfsen HC, Hemminger LI. Photodynamic<br />
therapy for dysplastic Barrett’s esophagus and<br />
mucosal adenocarcinoma. Gastrointest Endosc<br />
2004;59:A251.<br />
101. Wolfsen HC, Hemminger LL, Raimondo M,<br />
Woodward TA. Photodynamic therapy and<br />
endoscopic mucosal resection for Barrett’s dysplasia<br />
and early esophageal adenocarcinoma. South Med J<br />
2004;97:827–30.<br />
102. Wolfsen HC, Hemminger LL, Wallace MB, Devault<br />
KR. Clinical experience of patients undergoing<br />
photodynamic therapy for Barrett’s dysplasia or<br />
cancer. Aliment Pharmacol Ther 2004;20:1125–31.<br />
155
Change language